Navigation Links
Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
Date:10/31/2012

-related.

This study was part of the Phase 2 program of SAR236553/REGN727, an investigational, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) that is currently being studied in the ODYSSEY Phase 3 trials for the lowering of low-density lipoprotein cholesterol (LDL-C).  Preclinical studies have shown that inhibiting PCSK9 leads to an increase in LDL receptors, which bind to LDL-C and clear it from the blood stream.  The publication can be accessed at http://www.nejm.org.

Additionally, new data from the Phase 2 studies of SAR236553/REGN727 will be presented at oral sessions at the American Heart Association's Scientific Sessions 2012 (AHA).  Results of these presentations are embargoed until the times listed below.  The presentations are:

Embargoed until November 6, 2012 at 9:30 AM PST:

  • Effect of SAR236553/REGN727 Fully Human Monoclonal Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Antibody on Plasma Lipoprotein(a) Concentrations: Pooled Analysis from Three Phase 2 Studies.  Tuesday, November 6, 2012, 9:30-9:45 AM PST.  Presenter: Daniel Gaudet, M.D., Professor of Medicine, University of Montreal. [Abstract No. 14725]
  • Embargoed until November 6, 2012 at 4:45 PM PST :

  • Effect of REGN727/SAR236553 Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Fully Human Monoclonal Antibody in Patients with Elevated Triglycerides/Low High-Density Lipoprotein Cholesterol: Data from Three Phase 2 Studies.  Tuesday, November 6, 2012, 4:45-5:00 PM PST.  Presenter: Robert Dufour, M.D., M.Sc., Associate Director, Institut de Recherches Cliniques de Montreal. [Abstract No. 16127]
  • About PCSK9
    PCSK9 is known to contribute to circulating LDL-C levels, as it binds to LDL receptors resulting in their degradation so that fewer are available on liver cells to remove LDL-C f
    '/>"/>

    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Sanofi Pasteur to add 2D barcode to six more vaccines
    2. Sanofi US Launches Collaborate Activate Innovation Challenge
    3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
    4. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
    5. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
    6. Regeneron Announces September 2012 Investor Conference Presentations
    7. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    8. Regeneron Announces June 2012 Investor Conference Presentations
    9. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    10. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    11. BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... 2015 Securities lawyers at Dunnam & ... Ltd. (NASDAQ: SLXP ) in connection with ... investors are encouraged to contact attorney Hamilton Lindley by ... focuses upon the shareholder value of the transaction. Under ... only $158.00 per share in cash. At least one ...
    (Date:2/27/2015)... , February 27, 2015 Report ... study showing you trends, R&D progress, and predicted revenues ... heading? What are the commercial prospects for this market ... potential revenues and other trends to 2025, discussing data, ... lets you assess regenerative medicine : cell-based therapies ...
    (Date:2/27/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, announced today that Keith ... present live at VirtualInvestorConferences.com on March 5th. ... for this Company update," said Mr. Murphy. "We ... of the exVive3D Liver, Bioprinted Human Tissue, commercialization ...
    Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
    (Date:2/27/2015)... 2015 Royal River Natural Foods, a locally-owned ... study that found adults who got the most magnesium were ... compared to those who got the least magnesium, with the ... The report is part of the March 2015 issue of ... Natural Foods publishes free each month for the Freeport community ...
    (Date:2/27/2015)... Adding to its rich history ... Advertising & Marketing has added Sedation Systems of ... patented NITROUSEAL® N20 closed mask and breathing circuit ... , Sedation Systems, http://www.sedationsystems.com is dedicated ... level, though it focuses primarily on pediatric patients. ...
    (Date:2/27/2015)... (PRWEB) February 27, 2015 FACE ... therapies, has announced a unique combination to take ... neck. Ultherapy Décolletage is a new treatment introduced ... noninvasive procedure specifically indicated to improve lines and ... for any person who suffers from the stubborn ...
    (Date:2/27/2015)... 2015 The Nashville periodontist ... scholarship for rising freshmen undergraduate students. , The Advanced ... specializing in many periodontal procedures such as dental ... gum disease . In honor of their 25th anniversary, ... eligible rising freshmen undergraduate students. , Students interested ...
    (Date:2/27/2015)... Ford, Pennsylvania (PRWEB) February 27, 2015 ... the Spring Breast Augmentation Special at his Chadds Ford, ... 13 through May 1, 2015, and will be priced ... to the latest silicone implants, it will include more ... price and $250 worth of free Dysport. , Space ...
    Breaking Medicine News(10 mins):Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3
    ... nasal spray to quash allergy symptoms may work better ... an "as-needed'', rather than daily basis, the nasal spray ... sneezing and congestion more effectively than the antihistamine loratadine ... fights allergy symptoms by reducing the inflammation that occurs ...
    ... intravenous magnesium sulfate to standard emergency department migraine ... enhance the effectiveness of treatment.// Dr. Jill Corbo, ... Medicine in the Bronx, New York, note that ... in the treatment of migraine headache and that ...
    ... to bear an underweight child, but some women may ... susceptibility.// The finding could help medicine better determine the ... they were not recommending at this point that women ... ,"Our data demonstrate that a subgroup of pregnant ...
    ... that butterbur extract is an effective antihistamine without any ... an active biochemical agent,// otherwise it would not work ... react with other medications. ,It was used ... either butterbur extract tablets or the usually used non-sedating ...
    ... 40,000 more lives each year worldwide if more people at ... it, doctors said.// An analysis of nearly 300 clinical ... prevent blood clots confirmed that aspirin reduces heart attacks and ... people who could benefit from aspirin and anti-platelet therapy receive ...
    ... stones, which are often extremely painful to excrete, cost ... lost productivity. While the stones can sometimes be prevented ... the bladder frequently,// medication to reduce the excretion of ... increase cholesterol and can cause bloating and other uncomfortable ...
    Cached Medicine News:
    ... I (cTnI) has been useful in the ... Departments (ED) with chest pain. 18-20 ... blood levels of sensitive and specific biomarkers, ... of creatine kinase (CK-MB), and myoglobin, are ...
    ... potent, naturally secreted estrogen and is the ... In the ovary, estradiol is produced from ... potent estrogen derived from androstenedione. Estrone and ... In men, small amounts of estradiol are ...
    ... Aio! 2nd generation cardiac troponin ... sensitive immunoassay providing quantitative results ... less than 18 minutes. The ... unique combination of antibodies that ...
    ... The VITROS ECi brings true automation ... immunodiagnostic testing. Highly sensitive assays for ... and bone metabolism testing are currently ... development. The VITROS ECi can simultaneously ...
    Medicine Products: